Floatz logo

ONC 206

Gliomatosis Cerebri

Jazz PharmaceuticalsSmall moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Gliomatosis Cerebri cohort.

Asset / SponsorPhaseRating
Valproic Acid
University of Göttingen
Phase 3BB
Inno-206
Meyer Children's Hospital IRCCS
Phase 2CCC
DEXAMETHASONE
Pediatric Brain Tumor Consortium
Phase 1CC
HSV-1716
Pediatric Brain Tumor Consortium
Phase 1CC
Palbociclib
Pediatric Brain Tumor Consortium
Phase 1CC
FDOPA
Erik Mittra
N/AD
Gefetinib
National Cancer Institute (NCI)
Phase 1/2NR

Same molecule, other indications

ONC 206 is also rated in:

grade II meningiomaDormant
CC
Indicative ·
43 / 100
View asset →
ependymomaDormant
CC
Indicative ·
43 / 100
View asset →
central nervous system cancerDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →